Liver Fibrosis
📧 Sign up to get email alerts when something new happens for Liver Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
This update reports on the FORCE trial evaluating FibroScan, a non-invasive liver fibrosis assessment tool, in pediatric cholestatic liver d…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Find HDV and Determine Its Status in Turkey
A Turkish clinical trial is currently recruiting to Find HDV and determine its status, focusing on hepatitis D infection and related liver c…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin [EARLY_Phase 1]
An EARLY Phase 1 clinical trial from PGIMER Chandigarh evaluating dapagliflozin for metabolic dysfunction-associated steatotic liver disease…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel [NA]
This clinical trial update describes a pediatric liver fibrosis evaluation using a fibrosis panel in the context of liver transplantation, a…
-
CLINICAL_TRIALS research · 2024-08-05Clinical Trial Update: Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit [NA]
A clinical trial update noting completion of a study that screened for advanced chronic liver disease using transient elastography in patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Global Research Initiative for Patients Screening on MASH
A clinical trial update shows recruitment is ongoing for the Global Research Initiative for Patients Screening on MASH, enrolling participan…
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: Reducing Non-Alcoholic Steatohepatitis [NA]
Clinical trial update noting enrollment by invitation for a study addressing non-alcoholic steatohepatitis and related liver conditions, spo…
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: Prediction of Significant Liver Fibrosis
A clinical trial investigating predictive methods for significant liver fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: HIBOC = Hepatic Imaging Biomarkers in Obese Children
A pediatric trial protocol investigating hepatic imaging biomarkers (elastography and related techniques) in obese children to assess liver …
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Adiposity, Cardiometabolic and Neurocognitive Health Among Ethnic Groups: a Feasibility and Pilot Study
Feasibility and pilot study assessing adiposity, cardiometabolic health and neurocognitive function across ethnic groups. Recruitment is ong…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Precise Evaluation Criteria for Histological Regression of NASH Fibrosis
This clinical trial update from Beijing Friendship Hospital describes precise criteria for histological assessment of regression in NASH-rel…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Early Liver Disease Breath Detection
Owlstone Ltd reports an early-stage trial update evaluating breath-based detection for liver disease, including liver fibrosis and nonalcoho…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Different Doses of ZED1227 vs. Placebo in NAFLD [Phase 2]
Phase 2 trial comparing different doses of ZED1227 to placebo in non-alcoholic fatty liver disease with liver fibrosis; the study has comple…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy and safety of Rencofilstat in subjects with nonalcoholic steatohepatitis and advance…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Pirfenidone and Advanced Liver Fibrosis. [Phase 2]
Phase 2 trial update on pirfenidone for advanced liver fibrosis shows completion of the study.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis. [Phase 2]
Phase 2 trial comparing prolonged-release pirfenidone to placebo in compensated cirrhosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. [Phase 2]
Phase 2 study evaluating the efficacy, safety and tolerability of the combination of Tropifexor and Licogliflozin, as well as each monothera…
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis [Phase 2]
Phase 2 trial of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis (NASH) and liver cirrhosis has completed wit…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluating probiotics for non-alcoholic fatty liver disease and steatohepatitis; results have been pos…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis [Phase 2]
Phase 2 trial update of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis and stage 3 liver fibrosis; study com…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes [Phase 4]
Phase 4 trial exploring the effects of pioglitazone and evogliptin on hepatic fibrosis in patients with chronic hepatitis B and type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects [Phase 2]
Phase 2 trial update for CRV431 in NASH patients with F2-F3 fibrosis; study completed and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis [Phase 2]
Phase II trial completed evaluating Hydronidone capsules (F351) for liver fibrosis due to chronic Hepatitis B infection.
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operation [Phase 4]
Phase 4 clinical trial evaluating sildenafil for liver fibrosis in adolescents and adults after Fontan operation is underway, with status cu…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C [Phase 2]
Phase 2 trial update for BMS-986263 in adults with advanced hepatic fibrosis after curing hepatitis C; study completed with results posted i…